The Valley Desk

NCT03778229 · Interventional trial

Osimertinib Plus Savolitinib in EGFRm+/MET+ NSCLC Following Prior Osimertinib

Overall registry status Active not recruiting

Phase 2

Conditions Carcinoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov